304 related articles for article (PubMed ID: 21825246)
1. Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor.
Kerasnoudis A; Rockhoff M; Federlein J; Gold R; Krogias C
Arch Neurol; 2011 Aug; 68(8):1073. PubMed ID: 21825246
[TBL] [Abstract][Full Text] [Related]
2. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
3. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
Finsterer J; Voigtländer T; Grisold W
J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
[TBL] [Abstract][Full Text] [Related]
4. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
[TBL] [Abstract][Full Text] [Related]
6. Rhombencephalitis associated with isolated Zic4-antibodies in Paraneoplastic cerebellar degeneration: a case report.
Loehrer PA; Timmermann L; Pehl A; Bien CI; Pfestroff A; Pedrosa DJ
BMC Neurol; 2020 May; 20(1):208. PubMed ID: 32450842
[TBL] [Abstract][Full Text] [Related]
7. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
Xia K; Saltzman JR; Carr-Locke DL
MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach.
Kikuchi H; Yamada T; Okayama A; Hara H; Taniwaki T; Shigeto H; Sasaki M; Iwaki T; Kira J
Fukuoka Igaku Zasshi; 2000 Apr; 91(4):104-9. PubMed ID: 10826224
[TBL] [Abstract][Full Text] [Related]
9. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
Storstein A; Krossnes BK; Vedeler CA
Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
[TBL] [Abstract][Full Text] [Related]
11. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
[TBL] [Abstract][Full Text] [Related]
12. Anti-Yo antibody associated with occult fallopian tube carcinoma.
Selby KJ; Warner J; Klempner S; Konstantinopoulos PA; Hecht JL
Int J Gynecol Pathol; 2011 Nov; 30(6):536-8. PubMed ID: 21979588
[TBL] [Abstract][Full Text] [Related]
13. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?
Marignier R; Chenevier F; Rogemond V; Sillevis Smitt P; Renoux C; Cavillon G; Androdias G; Vukusic S; Graus F; Honnorat J; Confavreux C
Arch Neurol; 2010 May; 67(5):627-30. PubMed ID: 20457964
[TBL] [Abstract][Full Text] [Related]
15. Anti-ZIC4 associated paraneoplastic cerebellar degeneration in a patient with both diffuse large B-cell lymphoma and incidental smoldering multiple myeloma.
Eye PG; Wang B; Keung ES; Tagg NT
J Neurol Sci; 2018 Jan; 384():36-37. PubMed ID: 29249374
[No Abstract] [Full Text] [Related]
16. Paraneoplastic cerebellar degeneration in a woman with ovarian cancer.
Santillan A; Bristow RE
Nat Clin Pract Oncol; 2006 Feb; 3(2):108-12; quiz 1 p following 112. PubMed ID: 16462852
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence].
Zouiten O; Benbrahim Z; Amaadour L; Mellas N
Pan Afr Med J; 2019; 33():281. PubMed ID: 31692829
[TBL] [Abstract][Full Text] [Related]
18. Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature.
Mancuso M; Orsucci D; Bacci A; Caldarazzo Ienco E; Siciliano G
Arch Ital Biol; 2011 Sep; 149(3):318-22. PubMed ID: 22028093
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
Ogita S; Llaguna OH; Feldman SM; Blum R
Breast J; 2008; 14(4):382-4. PubMed ID: 18540952
[TBL] [Abstract][Full Text] [Related]
20. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.
Greenlee JE; Clawson SA; Hill KE; Dechet CB; Carlson NG
J Neurol Sci; 2010 Apr; 291(1-2):74-8. PubMed ID: 20089262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
